PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-01-30

Date Title Company
30-Jan-2020 Histogen and Allergan Expand Cell Conditioned Media (CCM) Skin Care Partnership Histogen Inc.
30-Jan-2020 Portage Announces Further Subscription of US$950,000 in Convertible Loan Notes to iOx Therapeutics and Provides Update on CTO Revocation Application Portage Biotech Inc.
30-Jan-2020 Cynbiose receives €1.9 million ($2.1M) to launch CYNBIOME, preclinical excellence network on microbiome and infectious diseases Cynbiose
30-Jan-2020 Genetesis Pilot study: 90-second scan shows promise in evaluating chest pain patients in Emergency Department observation unit Genetesis Inc.
30-Jan-2020 Genetesis Pilot study: 90-second scan shows promise in evaluating chest pain patients in Emergency Department observation unit Genetesis Inc.
30-Jan-2020 Diverse Biotech selected to speak at prestigious Pennsylvania Conferences Diverse Biotech, Inc
30-Jan-2020 Global Fibrin Sealants Market by Type, Product, Delivery Mode, End-User – Forecast to 2026 Wired Release
30-Jan-2020 Global Cyanocobalamin Spray Industry 2020 Research report and Forecast to 2026 Wired Release
30-Jan-2020 Cyanocobalamin Injection Industry 2020 Research report and Forecast to 2026 Wired Release
30-Jan-2020 European Medicines Agency Validates Kite's Marketing Authorisation Application for Company's Second CAR T Cell Therapy Kite
30-Jan-2020 ZyVersa Therapeutics Featured in Business Worldwide Magazine's Winter Edition as One of the 20 Most Innovative Companies to Watch ZyVersa Therapeutics, Inc.
30-Jan-2020 Abcam Expands Cell Engineering Capabilities Through Asset Purchase of Applied StemCell’s Gene Editing Platform and Oncology Product Portfolio ABCAM PLC
30-Jan-2020 REGULATORY ANNOUNCEMENT: Astellas Submits sNDA for Approval of Evrenzo® (roxadustat) Astellas Pharma Inc.
30-Jan-2020 Sanofi: Positive topline results demonstrated by olipudase alfa, first and only investigational therapy in late-stage development for acid sphingomyelinase deficiency Sanofi
30-Jan-2020 FDA accepts for priority review Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis Sanofi
30-Jan-2020 Autolus Announces Closing of Public Offering Autolus Therapeutics plc
30-Jan-2020 Agilent Introduces New Cutting-Edge SureSelect DNA Kit Agilent Technologies Inc.
30-Jan-2020 NuCana Announces First Patients Dosed in Both US and Europe in Phase III Study of Acelarin (NUC-1031) for the First-Line Treatment of Patients with Biliary Tract Cancer NuCana plc
30-Jan-2020 Akari Therapeutics Announces Preclinical Ophthalmic Data Showing Nomacopan Reduces Both Vascular Endothelial Growth Factor (VEGF) and Retinal Inflammation Supporting Nomacopan as a Potential Treatment Option for Back-of-the-Eye Diseases Akari Therapeutics
30-Jan-2020 PharmaMar and Bionical Emas launch Expanded Access Program for lurbinectedin in relapsed Small Cell Lung Cancer in the U.S. PharmaMar and Bionical Emas